Clinical Trial

Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization

Study acronym: Reducer
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to implant the Reducer in patients with the symptoms of refractory angina, that suffer from refractory angina who demonstrate reversible ischemia.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2012-03-27; most recent amendment 2022-02-01.
Status change: Not Yet Recruiting → Recruiting 2014-08-10
Trial Details
NCT Number NCT01566175
Lead Sponsor Tel-Aviv Sourasky Medical Center
Collaborators: Shockwave Medical, Inc.
Conditions Refractory Angina
Enrollment 100 participants
Start Date 2011-08-30
Primary Completion 2030-12-31 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2022-02-02